All Pharma News
Molecure Approved For OATD-01 Pulmonary Sarcoidosis Phase 2 In EU, Norway

Molecure Approved For OATD-01 Pulmonary Sarcoidosis Phase 2 In EU, Norway
GLOBENEWSWIRE
21 May 2024
Share Share
Molecure has Published Its Financial Report for 2023

Molecure has Published Its Financial Report for 2023
GLOBENEWSWIRE
03 Apr 2024
Share Share
First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in PS

First patient in the UK is dosed in the OATD-01 Phase 2 KITE study in PS
GLOBENEWSWIRE
22 Mar 2024
Share Share
Molecure Announces Third Quarter 2023 Financial Results and Pipeline Highlights

Molecure Announces Third Quarter 2023 Financial Results and Pipeline Highlights
GLOBENEWSWIRE
31 Oct 2023
Share Share
Molecure Announces First Half 2023 Results Significant Financial Momentum

Molecure Announces First Half 2023 Results Significant Financial Momentum
GLOBENEWSWIRE
29 Sep 2023
Share Share
FDA Gives Green Light to Molecure`s Program PII Testing of OATD-01 for Launch

FDA Gives Green Light to Molecure`s Program PII Testing of OATD-01 for Launch
GLOBENEWSWIRE
24 Jul 2023
Share Share
Molecure completes successful SPO of approximately PLN 50 million

Molecure completes successful SPO of approximately PLN 50 million
GLOBENEWSWIRE
21 Jul 2023
Share Share
Molecure gears up for Phase II sarcoidosis trial

Molecure gears up for Phase II sarcoidosis trial
Phalguni Deswal CLINICAL TRIALS ARENA
23 Jun 2023
Share Share
Molecure Files an (IND) application for lead clinical candidate OATD-01

Molecure Files an (IND) application for lead clinical candidate OATD-01
GLOBENEWSWIRE
23 Jun 2023
Share Share
Molecure Announces Full Year Financial 2022 Results

Molecure Announces Full Year Financial 2022 Results
GLOBENEWSWIRE
30 Mar 2023
Share Share